Overview

Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527

Status:
Completed
Trial end date:
2021-04-10
Target enrollment:
Participant gender:
Summary
This study will determine the effect of carbamazepine on the PK of AT-527 (RO7496998) in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Atea Pharmaceuticals, Inc.
Collaborator:
Hoffmann-La Roche
Treatments:
Carbamazepine